Loading insider details...
Beta
Latest Form 4 (Oct 16, 2026): Grant/Award of 20,300 IAM shares.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Company | Transaction | Shares | Value |
|---|---|---|---|---|
| Oct 16, 2026 | Iambic Therapeutics, Inc. (IAM) | Grant/Award | 20,300 | n/a |
| Aug 4, 2026 | Jasper Therapeutics, Inc. (JSPR) | Grant/Award | 7,500 | n/a |
| Jul 3, 2025 | Jasper Therapeutics, Inc. (JSPR) | Grant/Award | 7,500 | n/a |
| Jun 10, 2024 | Jasper Therapeutics, Inc. (JSPR) | Grant/Award | 7,500 | n/a |
| Mar 22, 2024 | CymaBay Therapeutics, Inc. (CBAY) | Disposition to Issuer | 90,000 | n/a |
| Jan 26, 2024 | CymaBay Therapeutics, Inc. (CBAY) | Grant/Award | 14,010 | n/a |
| Jun 8, 2023 | Jasper Therapeutics, Inc. (JSPR) | Grant/Award | 47,000 | n/a |
| Apr 14, 2023 | Jasper Therapeutics, Inc. (JSPR) | Sale | 9,075 | $13.5K |
| Oct 14, 2022 | Jasper Therapeutics, Inc. (JSPR) | Grant/Award | 30,250 | n/a |
| Mar 23, 2022 | Jasper Therapeutics, Inc. (JSPR) | Grant/Award | 78,045 | n/a |